上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
6-Diazo-5-oxo-L-nor-Leucine (Synonyms: L-6-Diazo-5-oxonorleucine; DON) 纯度: 99.92%
L-6-Diazo-5-oxonorleucine (L-6-Diazo-5-oxonorleucine) 是一种谷氨酰胺拮抗剂,其Ki 值为 6 μM。L-6-Diazo-5-oxonorleucine 具有抗菌、抗病毒和抗癌作用。L-6-Diazo-5-oxonorleucine 在体外表现出遗传毒性。L-6-Diazo-5-oxonorleucine 能降低肿瘤细胞的自我更新能力和转移能力 。
6-Diazo-5-oxo-L-nor-Leucine Chemical Structure
CAS No. : 157-03-9
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in Water | ¥5271 | In-stock | |
1 mg | ¥2800 | In-stock | |
5 mg | ¥3850 | In-stock | |
10 mg | 询价 | ||
50 mg | 询价 |
* Please select Quantity before adding items.
6-Diazo-5-oxo-L-nor-Leucine 相关产品
•相关化合物库:
- Bioactive Compound Library Plus
- Anti-Infection Compound Library
- Metabolism/Protease Compound Library
- Anti-Cancer Compound Library
- Antiviral Compound Library
- Antibacterial Compound Library
- Glutamine Metabolism Compound Library
- Antibiotics Library
- Anti-Cancer Metabolism Compound Library
- Mitochondria-Targeted Compound Library
生物活性 |
L-6-Diazo-5-oxonorleucine (L-6-Diazo-5-oxonorleucine) is a glutaminases antagonist with a Ki of 6 μM. L-6-Diazo-5-oxonorleucine exhibits antibacterial, antiviral and anticancer properties. L-6-Diazo-5-oxonorleucine displays genetic toxicity in vitro. L-6-Diazo-5-oxonorleucine decreases the self-renewal potential and metastatic ability of tumor cell[1][2][3][4]. |
IC50 & Target |
Ki: 6 μM (glutaminases)[4] |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
分子量 |
171.15 |
||||||||||||||||
Formula |
C6H9N3O3 |
||||||||||||||||
CAS 号 |
157-03-9 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
-20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||||||||||||
溶解性数据 |
In Vitro:
H2O : 50 mg/mL (292.14 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务